Pipeline DiversificationThe company's diversified pipeline and multiple partnerships provide significant optionality, supporting an Outperform rating.
Product LaunchCasgevy's launch shows an uptick with expected acceleration due to expanding ATCs network and increasing payer coverage.
Strategic PartnershipsCRSP announced a partnership with Sirius Therapeutics to develop and commercialize SRSD107, a next-generation, long-acting Factor XI siRNA for the treatment of blood clotting disorders.